Colorectal cancer (CRC) is the second most prevalent cause of death from cancer in the Western world ([@bib47]). One third of the 147,000 patients diagnosed with CRC every year in the United States will succumb to the disease ([@bib47]). Significant progress has been made in revealing somatic genetic alterations in CRC, ranging from the now classical adenoma--carcinoma sequence to insights into genomic instability and patterns of accumulation of somatic mutations at distinct genes and loci ([@bib40]; [@bib13]). Epidemiological studies support environmental factors such as obesity as being important in the pathogenesis of cancer, including CRC ([@bib12]; [@bib1]).

CRC arises from the intestinal epithelium, a highly proliferative tissue which renews itself every several days under steady-state conditions. Upon intestinal epithelial injury and cell loss, such homeostatic renewal is supplanted by a regenerative response, which also represents an important defense strategy of the host ([@bib2]; [@bib15]; [@bib35]). However, an unabated regenerative, wound healing--like response to tissue injury may lay the ground for intestinal tumors ([@bib42]). This is clinically evident by the common occurrence of tumors at sites of chronic injury (e.g., colitis-associated cancer \[CAC\] in inflammatory bowel disease \[IBD\] or gastric cancer upon *Helicobacter pylori* infection). Hence, the remarkable paradox emerges that cell death caused by tissue injury augments the tumorigenic potential of adjoining cells ([@bib42]). Inflammatory signals from the chronically inflamed intestinal microenvironment, such as IL-6 and IL-11 among others, have been identified to contribute to such tumor-promoting activities in the injured intestine ([@bib5]; [@bib9]; [@bib26]).

In mammals, the intestinal epithelial compartment consists of several subtypes of differentiated cells (absorptive, Paneth, goblet, and enteroendocrine cells) that arise from rapidly cycling Lgr5^+^Olfm4^+^ intestinal stem cells (ISCs) at the crypt bottom ([@bib3]). This Lgr5^+^ stem cell population also gives continuous rise to a quiescent label-retaining population, located at the +4 position and expressing Lgr5, that is committed to mature into Paneth and enteroendocrine cells, but which can alternatively be recalled to the stem cell state within the crypt in instances of injury to the crypt ([@bib68]; [@bib55]; [@bib76]; [@bib78]; [@bib11]; [@bib14]). ISCs feed into transit-amplifying cells, which serve as the forerunners of the differentiated intestinal epithelial cell (IEC) types ([@bib3]). Through a model of human sporadic and familial CRC, ISCs have been revealed as the cells of origin of intestinal cancer ([@bib4]; [@bib92]; [@bib70]).

The unfolded protein response (UPR) is a cytoprotective response to ER stress that arises when misfolded proteins accumulate in this organelle ([@bib71]; [@bib79]; [@bib85]). In metazoans, three core UPR-associated pathways coordinate an adaptive response to ER stress that results in expansion of the ER, promotion of ER-associated degradation and chaperone functions and, when unabated, cellular death by apoptosis. The evolutionarily most conserved UPR branch consists of inositol-requiring enzyme 1α (Ire1α; encoded by *Ern1*), an ER stress sensor, and the transcription factor X-box--binding protein 1 (Xbp1) as its effector ([@bib71]; [@bib66]; [@bib79]; [@bib41]; [@bib85]). Ire1α activates Xbp1 by conversion of unspliced Xbp1 (Xbp1u) mRNA to spliced Xbp1 (Xbp1s) via its atypical endoribonuclease function, which removes 26nt within Xbp1u to generate an alternate reading frame (Xbp1s; [@bib31]; [@bib85]). Unresolved ER stress in IECs has emerged as an important mechanism that initiates inflammation in the intestine ([@bib38]). Specifically, partial or complete *Xbp1* deletion in mouse IECs leads to unresolved ER stress and consequently hypersensitivity of IECs to inflammatory and microbial signals, Paneth cell dysfunction with loss of their characteristic granules, increased epithelial apoptosis, spontaneous small intestinal enteritis, and increased susceptibility to colitis-inducing agents ([@bib38]). Fittingly, hypomorphic *XBP1* variants confer genetic risk for both forms of IBD, Crohn's disease and ulcerative colitis ([@bib38]). Additional genetic risk factors that impact the UPR have been discovered in IBD (e.g., *ORMDL3* \[[@bib52]\] and *AGR2* \[[@bib91]\]), and in some cases their genetic deletion in mice can lead to spontaneous IBD-like disease as well ([@bib90]). Notably, it appears that IECs in IBD generally experience unresolved ER stress, even in the absence of overt tissue-destructive inflammation ([@bib29]; [@bib38]; [@bib80]), with the effectiveness of the UPR being under the influence of primary (genetic) and secondary (environmental) factors ([@bib37]). Prompted by the increased turnover of IECs in mice that lack *Xbp1* ([@bib38]), here we investigated the UPR's role in epithelial regeneration and its implications for intestinal tumorigenesis.

RESULTS
=======

Xbp1 deletion increases ISC numbers
-----------------------------------

The *Xbp1*-deficient small intestinal epithelium exhibits increased turnover ([@bib38]), which is similarly present in the colon ([Fig. 1, A and B](#fig1){ref-type="fig"}). A 2-h pulse of BrdU revealed expansion of the transit-amplifying zone in the ileum and colon, whereas a 24-h pulse demonstrated accelerated migration of IECs along the crypt--villus axis in IEC-conditional knockout *Xbp1^−/−(IEC)^* mice compared with *Xbp1^+/+(IEC)^* littermates ([Fig. 1, A--C](#fig1){ref-type="fig"}). This corresponded with increased numbers of proliferating cell nuclear antigen (PCNA)^+^ cells along the crypt--villus axis in *Xbp1^−/−(IEC)^* mice ([Fig. 1, D and E](#fig1){ref-type="fig"}). Moreover, deletion of *Xbp1* resulted in a 57 ± 3% increase in Olfm4^+^ ISCs ([Fig. 1, F and G](#fig1){ref-type="fig"}). This correlated with an increased number of BrdU^+^ cells at the crypt base consistent with proliferating ISCs ([Fig. 1 H](#fig1){ref-type="fig"}). In situ hybridization (ISH) for Lgr5 indicated increased expression in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^*, both in the small intestine and colon ([Fig. 1 I](#fig1){ref-type="fig"}). This was also reflected by a trend toward increased *Lgr5* mRNA expression in isolated crypts upon quantification by RT-PCR ([Fig. 1 J](#fig1){ref-type="fig"}) and significantly increased expression of characteristic mRNAs that define the ISC signature ([Fig. 1 J](#fig1){ref-type="fig"}; [@bib69]; [@bib57]). Altogether, these data indicate an expansion of ISC numbers in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* mice. This increase in ISCs is interesting because Paneth cells, which contribute to the ISCs' niche to a variable extent depending on the model system studied ([@bib69]; [@bib17]; [@bib39]; [@bib87]), are morphologically condensed to Paneth cell remnants that lack their characteristic secretory apparatus when *Xbp1* is deleted ([@bib38]). Among the genes that had been reported as most highly enriched in Paneth cells and that could support a niche function for ISCs are *Wnt3*, *Wnt11*, *Egf*, *Tgfa*, and *Dll4* ([@bib69]). Among those, we noted a threefold increase in mRNA expression of *Wnt11* in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* crypts ([Fig. 1 K](#fig1){ref-type="fig"}).

![***Xbp1* deletion increases ISC numbers.** (A) Animals were injected with BrdU and sacrificed 24 h later. BrdU^+^ cells per total cells along the crypt--villus axis were counted (*n* = 3/4; two-tailed Student's *t* test). (B) Anti-BrdU IHC of the ileum and colon 24 h after i.p. injection with BrdU (*n* = 3/4). (C) Similar experiment as A with a 2-h BrdU pulse to assess transit-amplifying cells (*n* = 4/4; two-tailed Student's *t* test). (D) Anti-PCNA IHC of the small intestine (*n* = 5/5). (E) PCNA^+^ cells per total cells along the crypt--villus axis were counted (*n* = 5/5; two-tailed Student's *t* test). (F) Olfm4^+^ ISCs (ISH; red arrowheads) in the small intestine of *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* mice. Lysozyme staining identified fully differentiated Paneth cells (black arrowheads) intermingled with ISCs (*n* = 3/4). (G) Quantification of Olfm4^+^ ISCs per 100 crypts (*n* = 3/4; two-tailed Student's *t* test). (H) Sections of *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* mice from C were analyzed for BrdU^+^ cells at the crypt bottom up to position +4 (*n* = 4/4). (I) ISC identification by Lgr5 ISH in ileum and colon (Lgr5^+^ crypts marked by red arrowheads; *n* = 4/4). Bars: (B, D, and I) 20 µm; (F) 5 µm. (J and K) Analysis of isolated crypt mRNA of *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* mice for transcripts representative of the ISC signature (J; [@bib57]) or Paneth cell signature (K; [@bib69]) by RT-pPCR (*n* = 12/11; Student's *t* test). Graphs show mean ± SEM. §, P = 0.0548; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20122341_Fig1){#fig1}

ISC expansion is dependent on overactivation of Ire1α
-----------------------------------------------------

The design of the floxed *Xbp1* allele results in a premature stop codon upon Cre-mediated deletion of exon 2, but it retains the capacity to monitor the splicing status of *Xbp1* mRNA ([@bib38]). Reduced or absent Xbp1 function in IECs leads to profound splicing of *Xbp1* mRNA ([@bib38]), which is consistent with unresolved ER stress and indicative of massive Ire1α activation ([@bib31]). Indeed, although Ire1α phosphorylation was not detectable in *Xbp1^+/+(IEC)^* epithelium, *Xbp1* deletion resulted in strong Ire1α phosphorylation, along with increased expression of total protein ([Fig. 2 A](#fig2){ref-type="fig"}). To test whether Ire1α is involved in ISC activation under ER stress, we generated double-conditional *VCre;Ern1^fl/fl^;Xbp1^fl/fl^* mice. [Fig. 2 (B and C)](#fig2){ref-type="fig"} shows abrogation of the increase in ISC numbers in the small intestine of *Xbp1^−/−(IEC)^;Ern1^−/−(IEC)^* compared with *Xbp1^−/−(IEC)^;Ern1^+/+(IEC)^* mice, with *Xbp1^−/−(IEC)^;Ern1^+/−(IEC)^* mice exhibiting an intermediate phenotype. In contrast, under homeostatic conditions in *Xbp1*-sufficient IECs (*Xbp1^+/+(IEC)^*), Ire1α did not affect the size of the ISC pool ([Fig. 2 D](#fig2){ref-type="fig"}). The floxed exons 20 and 21 of the *Ern1* allele encode the endoribonuclease domain of Ire1α, whereas the kinase domain is encoded upstream and remains intact ([@bib34]). In *Ern1^−/−(IEC)^* mice, a truncated Ire1α protein was detectable ([Fig. 2 E](#fig2){ref-type="fig"}) that lacked the capacity for massive Xbp1 mRNA splicing in *Xbp1*-deficient IECs of double mutant mice ([Fig. 2 F](#fig2){ref-type="fig"}), as expected, and indeed was not phosphorylated under ER stress, demonstrating loss of its endoribonuclease and kinase activity ([Fig. 2 A](#fig2){ref-type="fig"}). In addition to ubiquitously expressed Ire1α, IECs express another isoform (Ire1β) with the capacity to splice *Xbp1* mRNA ([@bib6]). It is therefore remarkable that genetic co-deletion of Ire1α (*Xbp1^−/−(IEC)^;Ern1^−/−(IEC)^*) alone was sufficient to completely revert the massive splicing of *Xbp1* mRNA to the baseline levels observed in *Xbp1*-sufficient IECs ([Fig. 2 F](#fig2){ref-type="fig"}). This implies that Ire1β is not overactivated in a similar way as is Ire1α as a consequence of ER stress caused by Xbp1 deletion. Hence, Ire1α drives regenerative ISC expansion upon sensing ER stress in the intestinal epithelium, but it is not involved in homeostatic ISC regulation. In contrast to ISC expansion, Ire1α did not affect the hyperproliferation of the ER-stressed, *Xbp1*-deleted intestinal epithelium ([Fig. 2 G](#fig2){ref-type="fig"}). Collectively, these data indicate that although hyperproliferation and ISC expansion are both consequences of *Xbp1* deletion and presumably ER stress, only the increase in ISC numbers is under the control of Ire1α.

![**ISC expansion is dependent on overactivation of Ire1α.** (A) Immunoblot of total and phosphorylated Ire1α of indicated genotypes in total epithelial scrapings or after immunoprecipitation (IP) as indicated. Samples were immunoprecipitated with anti-Ire1α pAb H-190 (immunogen: amino acids 371--560) and immunoblotted with anti-Ire1α mAb 14C10 (immunogen: C-terminal fragment) or pAb H-190. Data are representative of four independent experiments. (B) Sections of the indicated genotypes were in situ hybridized for Olfm4 (red arrowheads), stained for lysozyme (black arrowheads), or both (*n* = 5 per group). Bars, 5 µm. (C) Quantification of Olfm4^+^ ISCs per 100 crypts (*n* = 5 per group with combined analysis of duodenum, jejunum, and ileum; one-way ANOVA with Bonferroni post-hoc test). (D) Quantification of Olfm4^+^ ISCs in *Ern1^+/+(IEC)^*, *Ern1^+/−(IEC)^*, and *Ern1^−/−(IEC)^* mice (*n* = 5 per group). (E) Western blot of *Ern1^+/+(IEC)^* and *Ern1^−/−(IEC)^* (exons 20--21 floxed) mice immunoblotted with mAb 14C10 and pAb H-190 detects a truncated Ire1α protein in *Ern1^−/−(IEC)^* epithelial scrapings. (F) Xbp1 mRNA splicing in epithelial scrapings of the indicated genotypes. 171 bp, Xbp1u; 145 bp, Xbp1s. (E and F) Data are representative of two independent experiments. (G) Animals were injected with BrdU and harvested 24 h later to assess epithelial turnover. BrdU^+^ cells per total cells along the crypt--villus axis were counted (*n* = 4 per group with combined analysis of duodenum, jejunum, and ileum; one-way ANOVA with Bonferroni post-hoc test). Graphs show mean ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20122341R_Fig2){#fig2}

Hypomorphic Xbp1 leads to Jak1/Stat3 activation in IECs
-------------------------------------------------------

In *Drosophila melanogaster*, injured enterocytes induce cytokines (*Upd*, *Upd2*, and *Upd3*) that activate Jak/Stat (*dome*, *hop*, and *STAT92E*) signaling in intestinal epithelial stem cells, which promotes their division and initiates progenitor cell differentiation ([@bib2]; [@bib35]). In the mammalian system, this feedback mechanism that links enterocyte loss to stem cell output is less well understood. The mammalian orthologues of the *Drosophila* pathway (IL-6, IL-11, and Stat3) play an important role in IEC regeneration ([@bib5]; [@bib9]; [@bib26]; [@bib61]). [Fig. 3 A](#fig3){ref-type="fig"} shows substantial levels of Stat3 Tyr-705 phosphorylation (p) in the *Xbp1^−/−(IEC)^* epithelium, whereas only minimal p-Stat3 was observed in *Xbp1^+/+(IEC)^* epithelium. Immunohistochemistry (IHC) localized p-Stat3 to the transit-amplifying zone with further extension into the villus epithelium, with barely any immunoreactivity demonstrable within the crypts ([Fig. 3 B](#fig3){ref-type="fig"}). Jak1 but not Jak2 phosphorylation was also induced in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* epithelium ([Fig. 3 A](#fig3){ref-type="fig"}). Total Stat3 as well as Jak1 and Jak2 was also increased ([Fig. 3 A](#fig3){ref-type="fig"}), which might reflect the known capacity of Stat3 to bind its own promoter and to transactivate its transcription ([@bib58]; [@bib43]; [@bib75]). Increased p-Stat3 was independent of Ire1α as *Xbp1^−/−(IEC)^;Ern1^−/−(IEC)^* and *Xbp1^−/−(IEC)^;Ern1^+/+(IEC)^* epithelia exhibited similar levels ([Fig. 3 C](#fig3){ref-type="fig"}). These experiments provide evidence for Ire1α-independent Stat3 activation in *Xbp1*-deficient epithelia that localizes to the transit-amplifying zone and its downstream progeny.

![**Hypomorphic Xbp1 leads to Jak1/Stat3 activation in the intestinal epithelium.** (A) Immunoblot for p-Stat3, Stat3, p-Jak1, Jak1, p-Jak2, and Jak2 on epithelial colonic scrapings. Data are representative of more than four independent experiments. (B) IHC localizes p-Stat3 immunoreactivity to IECs in the transit-amplifying zone and villus, but largely spares the crypt bottom (*n* = 3/3). Boxed areas are shown at higher magnification on the right. Bars, 20 µm. (C) Small intestinal epithelial scrapings from the indicated genotypes were analyzed for p-Stat3, Stat3, p-Jnk, and Jnk. The experiment was performed with four mice per group. (D) Mice were treated with the Stat3 inhibitor S3I-201 or vehicle for 14 d, and BrdU was administered 24 h before harvest. The ratio of BrdU^+^ cells per total IECs along the crypt--villus axis in the small intestine is presented (*n* = 4/5/7; one-way ANOVA with Bonferroni post-hoc test). (E) Olfm4^+^ ISCs counted in the same experiment as in D (*n* = 2/3/3; one-way ANOVA with Bonferroni post-hoc test). (F) MODE-K.*iXbp1* and MODE-K.*iCtrl* cells were stimulated with the ER stress inducer tunicamycin and analyzed for Stat3 Tyr-705 phosphorylation. Data are representative of two independent experiments. (G) *Il6* and *Il11* mRNA expression in MODE-K.*iXbp1* and MODE-K.*iCtrl* cells (*n* = 3; two-sided Student's *t* test). Data are representative of two independent experiments. (H) Supernatants from MODE-K.*iXbp1* and MODE-K.*iCtrl* cells were analyzed for IL-6 and IL-11 secretion by ELISA (*n* = 6; two-sided Student's *t* test). (I) MODE-K.*iXbp1* and MODE-K.*iCtrl* cells were incubated with anti--IL-11 and anti--IL-6 mAbs or respective isotype control antibodies, and Stat3 Tyr-705 phosphorylation was analyzed in cell lysates. Data are representative of three independent experiments. (J) MODE-K.*iXbp1* and MODE-K.*iCtrl* cells were co-silenced with *Jak1*-, *Jak2*-, *Jak3*-, and *Tyk2*-specific or scrambled siRNAs, and Stat3 Tyr-705 phosphorylation was analyzed. Data are representative of four independent experiments. (K) IECs of *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* mice were analyzed for p--NF-κB p65 and total NF-κB p65. Data are representative of two independent experiments. (L) The NF-κB inhibitor BAY 11-7082 or vehicle was administered to *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* mice for 2 wk, and Stat3 Tyr-705 phosphorylation was analyzed in small IEC scrapings. Data are representative of three independent experiments. (A, C, F, and I--L) Gapdh was used as a loading control. (M) Mice were treated with the Jnk inhibitor SP600125 or vehicle for 14 d, and Olfm4^+^ ISCs were counted (*n* = 5/6/7; one-way ANOVA with Bonferroni post-hoc test). (N) The ratio of BrdU^+^ cells per total IECs along the crypt--villus axis in the small intestine 24 h after BrdU administration is analyzed in the same experiment as in M (*n* = 5/6/7; one-way ANOVA with Bonferroni post-hoc test). Graphs show mean ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20122341R_Fig3){#fig3}

Stat3 blockade abrogates epithelial hyperproliferation in Xbp1-deficient epithelium
-----------------------------------------------------------------------------------

S3I-201 selectively inhibits Stat3 transcriptional activities by blocking dimer formation and DNA binding ([@bib74]). To test whether Stat3 is responsible for epithelial hyperproliferation in *Xbp1*-deficient IECs, we administered S3I-201 i.p. every other day for 14 d to *Xbp1^−/−(IEC)^* mice. [Fig. 3 D](#fig3){ref-type="fig"} demonstrates that Stat3 inhibition abrogated the increased turnover of the intestinal epithelium in *Xbp1^−/−(IEC)^* mice. Notably, S3I-201 did not affect ISC numbers in *Xbp1^−/−(IEC)^* mice ([Fig. 3 E](#fig3){ref-type="fig"}), which is consistent with an absence of p-Stat3 in crypts ([Fig. 3 B](#fig3){ref-type="fig"}). Of note, S3I-201 did not affect epithelial turnover in *Xbp1*-sufficient mice (not depicted), indicating that this Stat3-dependent mechanism is specifically engaged under conditions of ER stress. Altogether, these data establish that *Xbp1* deficiency results in Stat3 activation in the transit-amplifying zone, which mediates the hyperproliferation of ER-stressed IECs.

Hypomorphic Xbp1 induces an autocrine activation loop in IECs via NF-κB, IL-6/IL-11, and Stat3
----------------------------------------------------------------------------------------------

We chose the small IEC line MODE-K as a model system for studying the mechanisms underlying Stat3 activation and silenced *Xbp1* expression via a lentivirus expressing a specific shRNA ([@bib38]). Stable *Xbp1* silencing resulted in profound Stat3 Tyr-705 phosphorylation compared with control-silenced cells ([Fig. 3 F](#fig3){ref-type="fig"}). Stat3 Tyr-705 phosphorylation was also induced in *Xbp1*-sufficient MODE-K cells after ER stress induction via tunicamycin ([Fig. 3 F](#fig3){ref-type="fig"}). The extent of Stat3 phosphorylation in *Xbp1*-silenced MODE-K cells was not further augmented by incubation with tunicamycin ([Fig. 3 F](#fig3){ref-type="fig"}) and, in fact, decreased at the latest time point studied, likely reflecting the exhaustion of the compensatory UPR ([Fig. 3 F](#fig3){ref-type="fig"}). These experiments establish that Stat3 activation in IECs is likely to be an IEC-intrinsic consequence of unresolved ER stress.

IL-6 and IL-11 are prototypical Stat3-activating cytokines ([@bib89]). *Xbp1* silencing induced mRNA expression and protein secretion of IL-6 and IL-11 in MODE-K cells ([Fig. 3, G and H](#fig3){ref-type="fig"}). Neutralization experiments with anti-cytokine antibodies revealed that combined administration of anti--IL-6 and anti--IL-11 mAbs abrogated increased Stat3 phosphorylation in MODE-K.*iXbp1* cells ([Fig. 3 I](#fig3){ref-type="fig"}). Co-silencing of individual cytokine receptor--associated Janus tyrosine kinases (Jak1-3 and Tyk2; [@bib89]) in MODE-K.*iXbp1* cells revealed Jak1 as the critical kinase for Stat3 activation under ER stress conditions ([Fig. 3 J](#fig3){ref-type="fig"}). These data indicate that hypomorphic Xbp1 leads to induction of IL-6 and IL-11 secretion in IECs, which in turn activates Stat3 phosphorylation via a Jak1-dependent mechanism.

*Il6* is typically transactivated by NF-κB (and, e.g., also by Stat3; [@bib84]; [@bib89]). ER stress can lead to NF-κB activation via several mechanisms ([@bib84]). *Xbp1^−/−(IEC)^* IECs exhibited increased total NF-κB p65 and p-p65 compared with *Xbp1^+/+(IEC)^* mice ([Fig. 3 K](#fig3){ref-type="fig"}). Blocking NF-κB activation in *Xbp1^−/−(IEC)^* mice via the specific irreversible inhibitor of IκBα phosphorylation, BAY 11-7082 ([@bib62]), indeed abrogated Stat3 activation to baseline levels observed in *Xbp1^+/+(IEC)^* littermates ([Fig. 3 L](#fig3){ref-type="fig"}). Hence, hypomorphic Xbp1 function is associated with increased NF-κB--dependent activation of Stat3 in IECs.

Jnk inhibition in *Xbp1^−/−(IEC)^* mice does not affect ISC expansion or hyperproliferation
-------------------------------------------------------------------------------------------

Hypomorphic Xbp1 function had previously been reported to result in activation of Jnk, and pharmacological blockade of Jnk phosphorylation with the specific inhibitor SP600125 resulted in abrogation of elevated CXCL1 secretion in *Xbp1*-deficient IECs ([@bib38]). [@bib8] reported that Jnk regulates proliferation and the regenerative capacity of somatic stem cells in the *Drosophila* gut. Moreover, Jnk can be recruited to Ire1 via the adapter molecule tumor necrosis factor receptor--associated factor 2 (Traf2) under certain conditions of ER stress ([@bib82]). To test the hypothesis that Jnk activation may contribute to the Ire1α-dependent increase in ISC numbers or has a role in determining the increased proliferative output of the transit-amplifying zone, we administered SP600125 i.p. every other day for 14 d to *Xbp1^−/−(IEC)^* mice. As depicted in [Fig. 3 (M and N)](#fig3){ref-type="fig"}, SP600125 affected neither Olfm4^+^ ISC numbers nor IEC turnover along the crypt--villus axis. Furthermore, increased Jnk phosphorylation in IECs was indistinguishable between *Xbp1^−/−(IEC)^;Ern1^−/−(IEC)^* and *Xbp1^−/−(IEC)^* mice and hence not under the control of Ire1α ([Fig. 3 C](#fig3){ref-type="fig"}). These observations let us conclude that Jnk does not have a critical role in the hyperregenerative phenotype observed in the ER-stressed, *Xbp1*-deficient intestine.

Xbp1 protects from CAC
----------------------

Long-standing IBD may lead to CAC, which has served as a paradigm for the relationship between inflammation and cancer ([@bib27]; [@bib51]; [@bib16]). The mediators involved in regeneration of the ER-stressed, *Xbp1*-deficient intestinal epithelium, such as Stat3, IL-6/IL-11, and NF-κB, also cooperate to drive CAC ([@bib5]; [@bib24]; [@bib9]; [@bib26]; [@bib25]; [@bib42]). We therefore induced CAC by azoxymethane (AOM), followed by three cycles of dextran sodium sulfate (DSS; [Fig. 4 A](#fig4){ref-type="fig"}; [@bib24]). *Xbp1^−/−(IEC)^* mice developed \>10-fold more and larger colonic tumors compared with *Xbp1^+/+(IEC)^* littermate controls ([Fig. 4, B--D](#fig4){ref-type="fig"}). When analyzed at an early time point (day 15 after initiation), atypical regenerative lesions were only detected in *Xbp1^−/−(IEC)^*, but not in *Xbp1^+/+(IEC)^*, mice ([Fig. 4 E](#fig4){ref-type="fig"}). Similarly, reactive oxygen species (ROS) levels were increased fivefold in *Xbp1^−/−(IEC)^* relative to *Xbp1^+/+(IEC)^* epithelia at day 15 ([Fig. 4 F](#fig4){ref-type="fig"}), consistent with ROS generation in ER-stressed, *Xbp1*-deficient cells ([@bib48]) and increased severity of DSS colitis in *Xbp1^−/−(IEC)^* mice ([@bib38]). ROS can lead to DNA damage and thereby contribute to cancer initiation and progression ([@bib73]). Indeed, at day 15, *Xbp1^−/−(IEC)^* epithelia exhibited nuclear staining for p53 ([Fig. 4 E](#fig4){ref-type="fig"}), evidence for a DNA damage response ([@bib10]), together with a trend toward an increase in aneuploid cells compared with *Xbp1^+/+(IEC)^* IECs ([Fig. 4 G](#fig4){ref-type="fig"}). Moreover, Stat3 phosphorylation was increased in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* mice ([Fig. 4, H and I](#fig4){ref-type="fig"}). These observations imply that epithelial *Xbp1* deficiency is associated with a profound increase in tumorigenesis in CAC. Because IEC-specific *Xbp1* deficiency is associated with increased severity of DSS-induced colitis ([@bib38]), increased tumorigenesis in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* mice in the AOM/DSS model as observed here may result from a combination of inflammatory, tumor-promoting signals emanating from the more intense myeloid infiltrate ([@bib24]; [@bib9]; [@bib26]), as well as from IEC-intrinsic mechanisms.

![**Xbp1 suppresses CAC.** (A) Schematic overview of the AOM/DSS CAC model. (B) Representative H&E staining of colon of *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* at day 61 of AOM/DSS colitis. Individual tumors are highlighted by red dashed lines (one of three individual experiments; *n* = 4/3; total *n* = 13/10). (C and D) Tumor number (C) and area (D) in *Xbp1^+/+(IEC)^* and *Xbp1^−/−(IEC)^* at day 61 of AOM/DSS colitis (one of three individual experiments; *n* = 4/3; total *n* = 13/10; two-sided Student's *t* test). (E, top) Atypical regenerative foci (white dashed lines) identified on H&E stainings on day 15 of AOM/DSS colitis. Number of lesions per colon is shown. (bottom) Staining for p53 was analyzed by IHC (arrowheads, p53^+^ nuclei; HPF, high power field; *n* = 4/4; two-sided Student's *t* test). (F) ROS in colonic epithelium before (*n* = 6/7; two-sided Student's *t* test) and on day 15 of AOM/DSS (*n* = 5/5; two-sided Student's *t* test). (G) Detection of aneuploidy by analysis of DNA content with propidium iodide in isolated colonic IECs (*n* = 3/3; one-sided Student's *t* test; M1 = G~0~/G~1~; M2 = G~2~/S; M3 = aneuploid). (H) IHC on day 15 of the AOM/DSS model localizes increased p-Stat3 immunoreactivity to IECs (*n* = 4/4). Bars: (B) 2 mm; (E \[top\] and H) 50 µm; (E, bottom) 20 µm. (I) Western blot for p-Stat3, Stat3, p-Jak1, and Jak1 on colonic IEC scrapings on day 15 of the AOM/DSS model. Gapdh was used as a loading control. Data are representative of two independent experiments. Graphs show mean ± SEM. §, P = 0.1024; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20122341_Fig4){#fig4}

Epithelial Xbp1 suppresses tumor formation in *Apc^min/+^* mice
---------------------------------------------------------------

Inflammatory signaling is an important contributor to CAC but also to sporadic and familial CRC ([@bib63]; [@bib45]), with overlapping and distinct inflammatory pathways being involved ([@bib67]). ER stress in various organs, including the liver, skeletal muscle, adipose tissue ([@bib60]; [@bib22]; [@bib36]), and intestinal crypts ([@bib32]), is associated with obesity, which is epidemiologically closely associated with increased cancer incidence, most notably CRC ([@bib12]). CRC and CAC exhibit distinguishing features with regard to their molecular genetic underpinning; e.g., inactivating somatic mutations in *adenomatous polyposis coli* (*APC*) are very common and appear early as a rate-limiting step in CRC pathogenesis ([@bib40]; [@bib18]; [@bib13]) but late in CAC ([@bib46]). Germline mutations in *APC* also cause familial adenomatous polyposis. *APC*-associated CRC can be modeled in *Apc* mutant mice ([@bib56]). Such a model has enabled the determination that ISCs are the cells of origin in CRC ([@bib4]; [@bib92]; [@bib70]). The expansion of ISCs in *Xbp1^−/−(IEC)^* mice, and the desire to delineate the specific tumor-promoting role of *Xbp1* deficiency specifically in IECs, prompted us to investigate whether unresolved ER stress augments tumorigenesis in this CRC model.

*Xbp1^−/−(IEC)^* mice crossed onto an *Apc^min^* background (*Xbp1^−/−(IEC)^;Apc^min^*) developed twofold more tumors than their *Xbp1^+/+(IEC)^;Apc^min^* littermates ([Fig. 5, A--C](#fig5){ref-type="fig"}), along with lower blood hemoglobin levels reflecting intestinal blood loss ([Fig. 5 D](#fig5){ref-type="fig"}). Increased tumor numbers in *Xbp1^−/−(IEC)^;Apc^min^* mice were detected in the small intestine, but also the colon, where only few tumors typically develop in the *Apc^min^* model ([Fig. 5, C and E](#fig5){ref-type="fig"}). Colonic tumors are notable because *Xbp1* deletion does not induce colonic, but only small intestinal inflammation ([@bib38]), suggesting that ER stress--induced tumor promotion is independent of overt inflammation in the colon. Nonetheless, colonic tumors from *Xbp1^−/−(IEC)^;Apc^min^* mice exhibited increased *Il6* and *Il11* mRNA expression compared with those from *Xbp1^+/+(IEC)^;Apc^min^* littermate controls ([Fig. 5 F](#fig5){ref-type="fig"}). Tumors in *Xbp1*-deficient mice exhibited *Xbp1* deletion, excluding outgrowth from *Xbp1*-sufficient IECs (not depicted). Together, these experiments demonstrate that Xbp1 suppresses the growth of spontaneously arising intestinal tumors.

![**Epithelial Xbp1 suppresses tumor burden in *Apc^min^* mice.** (A) Representative macroscopic pictures of the colon with rectal tumors in the indicated genotypes analyzed at age 15 wk (*n* = 13/10). Boxed areas are shown at higher magnification on the right. (B) Representative H&E-stained sections, with tumors highlighted by dotted lines (*n* = 13/10). (C) Quantification of tumor numbers per mouse along the intestinal tract (*n* = 13/10; two-sided Student's *t* test). (D) Peripheral blood count of the indicated genotypes at age 15 wk (*n* = 13/10; two-sided Student's *t* test). (E) Ileal and colonic tumor counts in the indicated genotypes stratified by size of tumors (*n* = 13/10; two-sided Student's *t* test). (F) Tumors from colons of *Xbp1^+/+(IEC)^;Apc^min^* and *Xbp1^−/−(IEC)^;Apc^min^* mice were microdissected, and mRNA expression of the indicated targets was analyzed by qPCR (*n* = 5/5; two-tailed Student's *t* test). (G) Olfm4^+^ ISCs (red arrowheads; ISH) and lysozyme^+^ Paneth cells (black arrowheads; IHC) in the indicated genotypes (*n* = 4/4). Bars: (A) 5 mm; (B) 100 µm; (G) 5 µm. (H) Number of Olfm4^+^ ISCs per 100 crypts in *Xbp1^+/+(IEC)^;Apc^min^* and *Xbp1^−/−(IEC)^;Apc^min^* small intestines. The occasional presence of crypts with lysozyme^+^ mature Paneth cells among the vast majority of crypts with lysozyme^−^ Paneth cell remnants in *Xbp1^−/−(IEC)^;Apc^min^* mice allowed crypt-specific stratification of Olfm4^+^ cell enumeration in lysozyme^+^ and lysozyme^−^ crypts (*n* = 4/4; two-sided Student's *t* test). Graphs show mean ± SEM. §, P = 0.0519; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20122341R_Fig5){#fig5}

ISC expansion is individually determined in each Xbp1-deficient crypt
---------------------------------------------------------------------

The *Xbp1^−/−(IEC)^;Apc^min^* model serendipitously also afforded us the opportunity to study whether regulation of ISC numbers by Xbp1 was autonomously regulated within individual crypts or, alternatively, was a consequence of the inflammatory milieu of the inflamed small intestinal mucosa. Although lysozyme staining was absent in the vast majority of Paneth cells (i.e., Paneth cell remnants) in *Xbp1^−/−(IEC)^* epithelia ([Fig. 1 F](#fig1){ref-type="fig"}; [@bib38]), the occasional (∼5%) occurrence of crypts with intact lysozyme^+^ Paneth cells in *Xbp1^−/−(IEC)^;Apc^min^* epithelia (which is presumably caused by inefficient *Cre*-mediated *Xbp1* deletion and hence mosaicism or, alternatively, caused by effective adaptation to ER stress despite *Xbp1* deletion) allowed us to quantify Olfm4^+^ ISCs separately in crypts without (i.e., Paneth cell remnants) and with (i.e., normal, mature Paneth cells) lysozyme expression. Within the *Xbp1^−/−(IEC)^;Apc^min^* genotype, ISC expansion was solely noted in crypts with Paneth cell remnants, whereas crypts with intact lysozyme^+^ Paneth cells (in immediate vicinity to those without) exhibited ISC numbers indistinguishable from those found in the *Xbp1^+/+(IEC)^;Apc^min^* genotype ([Fig. 5, G and H](#fig5){ref-type="fig"}). These data suggest that expansion of ISCs is not merely a result of the surrounding proinflammatory milieu, which would similarly affect the occasional crypts with intact lysozyme^+^ Paneth cells, but an IEC-inherent, Xbp1- and ER stress--dependent, crypt-autonomous process.

Tumor formation in *Xbp1^−/−(IEC)^;Apc^min^* mice is dependent on Ire1α
-----------------------------------------------------------------------

Analogous to its role in ISC expansion under ER stress, we hypothesized that tumor formation in *Xbp1^−/−(IEC)^;Apc^min^* mice would be dependent on Ire1α. Hence, *Ern1^−/−(IEC)^;Xbp1^−/−(IEC)^;Apc^min^* mice would be predicted to be indistinguishable in tumor formation from *Apc^min^* mice. We generated mice that harbored floxed alleles for both *Xbp1* and *Ern1* that were also hemizygous for *Apc^min^* and compared littermates that expressed one allele of the *Villin-Cre* transgene with those that did not. We observed that deletion of *Ern1* in the intestinal epithelium eliminated the increased tumorigenesis caused by *Xbp1* deficiency in *Apc^min^* mice. Specifically, as depicted in [Fig. 6 (A--D)](#fig6){ref-type="fig"}, tumor numbers in *Ern1^−/−(IEC)^;Xbp1^−/−(IEC)^;Apc^min^* mice were indeed no longer significantly different from *Ern1^+/+(IEC)^;Xbp1^+/+(IEC)^;Apc^min^* mice, and even tended to be lower. These data indicate that increased tumor formation in *Apc^min^* mice consequent to *Xbp1* deletion is dependent on ER stress sensed by Ire1α and may, by inference, be related to the Ire1α-dependent activation of ISCs.

![**Increased tumor formation in *Xbp1^−/−(IEC)^;Apc^min^* mice is dependent on Ire1α.** (A) Representative macroscopic pictures of colonic tumors of the indicated genotypes analyzed at age 15 wk (*n* = 14/10). Boxed areas are shown at higher magnification on the right. Bars, 5 mm. (B) Enumeration of tumors in the indicated genotypes at 15 wk of age. Mean tumor numbers ± SEM along the intestinal tract are shown (*n* = 14/10; two-sided Student's *t* test). (C and D) Ileal (C) and colonic (D) tumor counts stratified by tumor size (*n* = 14/10; two-sided Student's *t* test). Graphs show mean ± SEM.](JEM_20122341_Fig6){#fig6}

DISCUSSION
==========

We report here that epithelial injury resulting from ER stress is a potent activator of IEC regeneration and promotes intestinal tumorigenesis. Hypomorphic Xbp1 causes ER stress that is sensed by Ire1α and increases ISC numbers, whereas Stat3 signaling, independent of Ire1α, increases the output of differentiated IECs. This organ-protective function, when sustained, augments tumor formation in both an inflammatory (i.e., CAC after DSS/AOM) and noninflammatory (i.e., CRC in *Apc^min^* mice) context. Cytokines and other factors originating from the more prominent inflammatory infiltrate in *Xbp1^−/−(IEC)^* mice exposed to DSS ([@bib38]) will likely contribute to increased tumorigenesis in the AOM/DSS CAC model ([@bib42]) through effects on the Ire1α-dependent and -independent pathways described here. However, it is clear that the hyperregenerative response observed in the setting of hypomorphic epithelial Xbp1 function is not only a consequence of increased inflammation as increases in colonic tumor formation were observed in *Apc^min^;Xbp1^−/−(IEC)^* mice, which is not associated with appreciable inflammation in this locale when *Xbp1* is deficient ([@bib38]). Moreover, increased tumor formation in *Xbp1*-deficient *Apc^min^* mice is dependent on Ire1α, linking ER stress sensing to increased intestinal tumorigenesis. This relationship has important ramifications as the UPR integrates microbial, environmental, and inflammatory signals at the mucosal surface and highlights an unexpected tumor-suppressive role of Xbp1 that is associated with the intestinal epithelium.

The UPR transcription factor Xbp1 is critical for IEC homeostasis in that its reduced function causes pathological ER stress and spontaneous enteritis in the small intestine ([@bib38]). As shown here, sensing of unresolved ER stress by Ire1α and its consequent overactivation is centrally related to increased ISC numbers observed in the *Xbp1*-deficient epithelium. Moreover, Ire1α does not notably affect homeostatic ISC function, but is only engaged as part of the regenerative response consequent to pathological ER stress. It might be speculated that this could involve regulated Ire1-dependent decay (RIDD) of mRNAs of as yet poorly defined proteins involved in restraining the ISC niche (e.g., Wnt or growth factor receptor antagonists or regulatory microRNAs \[[@bib81]\]). RIDD is engaged upon pathological ER stress and results in endonucleolytic degradation of ER-localized mRNAs ([@bib28]; [@bib33]).

Paneth cells secrete factors that support the proliferation of intermingled ISCs ([@bib69]). Paneth cells are particularly susceptible to impairment in the UPR as *Xbp1* deletion in IECs results in loss of their characteristic secretory granules (resulting in Paneth cell remnants); however, Paneth cell remnants remain juxtaposed to ISCs ([@bib38]). The direct relationship between ISC expansion and the presence of Paneth cell remnants within discrete crypts observed in the *Xbp1^−/−(IEC)^;Apc^min^* genotype ([Fig. 5 H](#fig5){ref-type="fig"}) also implies that ISC expansion may be autonomously regulated within individual crypts. *Xbp1* splicing (i.e., active Xbp1s) localizes to Paneth cells, transit-amplifying cells, and cells further up the crypt--villus axis, whereas ISCs do not express appreciable levels of *Xbp1s* ([@bib30]; [@bib72]), raising the possibility that ER stress in Paneth cell remnants may directly promote ISC expansion ([@bib69]). Increased expression of the Paneth cell--specific ([@bib69]) transcript *Wnt11* in *Xbp1^−/−(IEC)^* compared with *Xbp1^+/+(IEC)^* crypts may have a role as a trans-acting factor and deserves further exploration in vivo. Wnt11 has been shown to be expressed at elevated levels in patients with ulcerative colitis ([@bib88]), gastric carcinoma cell lines, and primary CRC cells ([@bib83]), and it can induce the proliferation and transformation of the IEC6 line in vitro ([@bib59]). Analogous to the model proposed in this paper, Paneth cells have recently been reported to sense calorie restriction (via mTORC1) and orchestrate ISC expansion in trans ([@bib87]). However, because *Vil-Cre* recombines in all IEC types (including ISCs), another possibility is that the effects of *Xbp1* deletion could also have yet-to-be-defined direct effects on ISCs themselves. However, ISCs express only minute levels of *Xbp1* and do not exhibit evidence of *Xbp1* splicing ([@bib30]; [@bib72]) under basal conditions. Neither of these hypotheses are mutually exclusive.

Although expansion of ISCs in the setting of ER stress was mediated by Ire1α, the increased turnover of *Xbp1*-deficient IECs was independent of Ire1α, suggesting different underlying mechanisms for both aspects of this regenerative response. An analogous discordant regulation of ISC expansion and proliferative output from transit-amplifying cells, and hence the engagement of separate mechanisms, has also been observed in the aforementioned study by [@bib87], in which sensing of calorie restriction via mTORC1 in Paneth cells led to increased ISC numbers but decreased proliferative output of differentiated epithelial cells. IEC-specific Stat3 is essential for epithelial restitution and wound healing upon injury, where it localizes with increased epithelial proliferation ([@bib61]). Indeed, *Xbp1* deletion, independently of Ire1α, leads to activation of Stat3 in the transit-amplifying zone. Consistent with this, pharmacologic blockade of Stat3 signaling abrogates heightened turnover of IECs in *Xbp1^−/−(IEC)^* mice. The secretion of the Stat3-activating cytokines IL-6 and IL-11 by *Xbp1*-silenced MODE-K cells suggests a feed forward loop instigated by ER-stressed IECs, which is relayed via Jak1. *Il6* is a prototypical NF-κB target gene ([@bib84]; [@bib89]), and *Il6* and *Il11* can be transactivated by Stat3 ([@bib89]). Given our observations here, it might be speculated that increased NF-κB activation as a consequence of pathological ER stress ([@bib86]; [@bib71]) in the *Xbp1*-deficient epithelium might be an inciting event that leads to excessive production of IL-6, which activates Stat3, which may further transactivate *Stat3*, *Il6*, and *Il11*. Indeed, pharmacologic blockade of NF-κB signaling abrogated Stat3 Tyr-705 phosphorylation in *Xbp1^−/−(IEC)^* epithelium.

Malignant cells are commonly exposed to hypoxia, nutrient deprivation, and pH changes that impact protein folding ([@bib50]; [@bib31]; [@bib49]). Human tumor cells indeed exhibit evidence of ER stress, and reduced capacity to elicit an UPR within malignant cells results in decreased tumorigenesis in model systems ([@bib50]; [@bib7]; [@bib19]; [@bib49]). Xbp1 has been considered protumorigenic ([@bib49]); Xbp1-deficient tumor cells exhibit impaired growth when xenografted into *Scid* mice ([@bib64], [@bib65]), and disruption of Ire1/Xbp1 signaling may be exploited pharmacologically for the treatment of multiple myeloma ([@bib44]; [@bib54]). Our data imply an unexpected tumor-preventive role of Xbp1 in the intestinal epithelium. In this rapidly renewing tissue that is constantly exposed to noxious stimuli that may impact protein folding, Xbp1 may not only assist in resolving ER stress but may thereby keep the regenerative response, including stem cell activation, in check. However, overwhelming the remedial abilities of Xbp1 (e.g., through genetic hypofunction of Xbp1 or persistence of microbial or environmental ER stressors including those that inhibit Xbp1 function; [@bib77]) may initiate a compensatory regenerative response, which is facilitative of neoplasias if persistent. In line with this, the architecture of ISCs in close proximity to Paneth cells is preserved in tumors ([@bib70]), which we speculate might result in a situation in which the increase in ISCs and proliferative output in *Xbp1^−/−(IEC)^* tumors may outcompete any potential survival disadvantage of differentiated epithelial cells caused by *Xbp1* deficiency.

Finally, the very mechanisms that appear critical for tumor initiation and promotion during CAC (NF-κB, IL-6, and Stat3; [@bib5]; [@bib24]; [@bib9]; [@bib26], [@bib27]; [@bib42]) are engaged when Xbp1 function is relatively insufficient. In parallel, the Ire1α-dependent expansion of the ISC compartment increases the stochastic chance for genotoxic damage in these cells of origin of intestinal cancer ([@bib4]; [@bib92]; [@bib53]; [@bib70]). Indeed, the Ire1α dependence of increased tumorigenesis in *Xbp1^−/−(IEC)^;Apc^min^* mice critically implies a fundamental role of ER stress sensing as a facilitator of CRC. Apart from integrating environmental, microbial, genetic, and inflammatory inputs that affect ER stress levels at the hostile intestinal surface, Ire1α itself might also be affected by somatic mutations in tumors. Indeed, it has ranked prominently as carrying driver mutations in a large-scale survey of the human kinase-ome in diverse human tumors ([@bib21]).

In summary, this study demonstrates an unexpected role of Xbp1 in restraining the development of CAC and noninflammation-associated CRC. These Xbp1-dependent effects mechanistically derive from a role for Xbp1 in regulating the activity of Ire1α, which in turn determines the size of the ISC pool and its propensity to develop intestinal neoplasias when perturbed, and in restraining an IEC-intrinsic inflammatory response that is mediated by NF-κB, IL-6, IL-11, and Stat3, which are directly involved in promoting IEC proliferation and expansion of the transit-amplifying compartment. Together, the unrestrained activity of the Ire1α-regulated ISC compartment and Stat3-mediated hyperproliferation are central to the development of colorectal neoplasia in the presence of hypomorphic Xbp1 function.

MATERIALS AND METHODS
=====================

### Mice.

*Xbp1^fl/fl^;VillinCre* (*Xbp1^−/−(IEC)^*) mice have been described previously ([@bib38]). *Ern1^fl/fl^;VillinCre*, *Xbp1^fl/fl^;Ern1^fl/fl^;VillinCre*, *Xbp1^fl/fl^;VillinCre;Apc^min^*, and *Ern1^fl/fl^;Xbp1^fl/fl^;VillinCre;Apc^min^* mice were generated by intercrossing *Xbp1^−/−(IEC)^* mice with *Apc^min^* (The Jackson Laboratory; [@bib56]) and *Ern1^fl/fl^* mice ([@bib34]). All mice were housed under specific pathogen--free conditions at Innsbruck Medical University, the University of Cambridge, and Harvard Medical School. The mating strategy involved keeping the *Cre* and *Apc^min^* alleles hemizygous so that nondeleted or non-*Apc^min^* offspring was generated at 50% and hence could be used as littermate controls. Mice were born at a Mendelian ratio, and mice on *Apc^min^* background were regularly surveyed for rectal bleeding and general health status. Mouse protocols were approved by the relevant authorities, and all procedures were performed in accordance with institutional guidelines, using gender- and age-matched littermate controls whenever possible. S3I-201 (EMD Millipore), SP600125 (Sigma-Aldrich), and BAY 11-7082 (EMD Millipore) were injected i.p. at 10 mg/kg, 30 mg/kg, and 5 mg/kg, respectively, in 6--8-wk-old mice every other day for 14 d.

### Antibodies.

Antibodies directed to p-Stat3 (Tyr705; D3A7), Stat3 (79D7), p-Jak1 (Tyr1022/1023), Jak1 (6G4), p-Jak2 (Tyr1007/1008; C80C3), Jak2 (D2E12), p--NF-κB p65 (Ser536; 93H1), NF-κB p65 (D14E12), Gapdh (14C10), Ire1α (14C10; all Cell Signaling Technology), Ire1α (H-190, Santa Cruz Biotechnology, Inc.), p-Ire1α (Ser724; Abcam), anti-lysozyme (Dako), p53 (CM5; Vector Laboratories), DIG (Roche), PCNA (PC10; Thermo Fisher Scientific), IL-6 (MP5-20F3), IL-11 (188520), IgG1 isotype control (43414), and IgG2A isotype control (54447; all R&D Systems) were used.

### AOM/DSS model.

6-8-wk-old *Xbp1^−/−(IEC)^* and *Xbp1^+/+(IEC)^* mice were injected i.p. with 12.5 mg/kg AOM (Sigma-Aldrich). Colitis was induced by two cycles of 2.5% DSS (MP Biomedicals) in drinking water for 5 d, followed by a 16-d tap water period ([Fig. 4 A](#fig4){ref-type="fig"}; [@bib24]). The final DSS cycle (2%) was administered for 4 d, followed by a 10-d tap water period. Tumor count and tumor area were determined at day 61 in paraffin-embedded hematoxylin and eosin (H&E)--stained "Swiss rolls." Serial sections every 200 µm were analyzed for tumor number and area using the section with the largest diameter for each individual tumor by Scion Image software (Scion Corporation).

### *Apc^min^* model.

Longitudinally cut formalin-fixed intestines of 15-wk-old *Xbp1^fl/fl^;VCre;Apc^min^* or *Ern1^fl/fl^;Xbp1^fl/fl^;VCre;Apc^min^* mice were analyzed under a stereomicroscope (SZH-ILLD; Olympus) and categorized according to their size ([@bib45]), complemented by H&E sections of paraffin-embedded Swiss rolls ([@bib63]). Complete blood count was performed using Vet abc plus^+^ (Scil animal care company GmbH).

### MODE-K cell cultures.

MODE-K IECs cultured in DMEM-10 were transduced with *Xbp1*-specific or control shRNA lentiviral vectors as described previously ([@bib38]), and stable clones were established. 10^5^ cells were seeded in 6-well plates overnight and *Jak1-3*, *Tyk2*, or control siRNA (Life Technologies) transfected, and experiments were harvested 68--72 h after transfection. Tunicamycin (Sigma-Aldrich) was added at 2 µg/ml and anti--IL-6/11 antibodies or isotype control antibodies at optimal concentrations of 2 µg/ml and 20 µg/ml, respectively, and IL-6 and IL-11 in supernatants were measured by ELISA (BD and R&D Systems, respectively).

### Crypt isolation.

Crypt isolation was performed as previously reported ([@bib57]). In brief, the small intestine was flushed with cold PBS and cut longitudinally. Subsequent to scraping on ice, which removed most villi, the intestine was cut into 5-mm pieces and incubated for 5 min in 5 mM EDTA/PBS. Pieces were placed in 30 mM EDTA/PBS for 30 min, passed through a 100-µm cell strainer, and centrifuged, RNA was isolated from crypts, and RT-qPCR was performed as described below.

### RNA extraction, RT-qPCR, and splicing assay.

RNA was isolated by the RNeasy Mini kit (QIAGEN). Total RNA was reverse transcribed with M-MLV RT (Invitrogen), and SYBR-Green (Eurogentec) qPCR was performed using MX-3000 (Agilent Technologies). Target gene expression is expressed as ratio to housekeeping gene expression. Splicing assay was performed as described previously ([@bib38]). See [Table S1](http://www.jem.org/cgi/content/full/jem.20122341/DC1){#supp1} for primer sequences.

### Western blotting.

Total protein lysates from MODE-K, IEC scrapings, or tissue were prepared in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS). Equal amounts of lysates containing Laemmli buffer were boiled at 95°C and resolved on 8--12.5% SDS-PAGE, and transferred, and Hybond-P polyvinylidene fluoride membranes (GE Healthcare) were blocked with 5% milk in TBS-T, overnight incubated with primary antibody, detected with HRP-conjugated secondary antibody, and visualized with LumiGLO (Cell Signaling Technology).

### Immunoprecipitations.

300 µg of protein lysate was incubated for 1 h with 1 µg anti-Ire1α pAb H-190 and pulled down with Sepharose-A. Pull-downs were washed three times with RIPA buffer and eluted with 2× SDS loading buffer, followed by Western blot analysis.

### IHC.

Sections were deparaffinized in xylol and dehydrated in ethanol. Antigen retrieval was performed using citrate or EDTA buffer for 15 min at sub-boiling temperature in a microwave, followed by blocking of endogenous peroxidases activity. Primary antibody was incubated overnight at 4°C, and secondary biotinylated antibody was detected with streptavidin-HRP (Vector Laboratories). Sections were developed using a DAB Peroxidase Substrate kit (Vector Laboratories). Images were acquired using an Axio Observer Z.1 and AxioCam MRc5 and analyzed with AxioVision software (release 4.8; all Carl Zeiss).

### ISH.

DIG-labeled sense and antisense cRNA probes ([@bib23]) from full-length cDNA clones (I.M.A.G.E. Consortium) were hybridized for 48 h at 500 ng/ml and visualized using anti-DIG antibody (Roche).

### Aneuploid cell fraction.

Extroverted intestines were incubated in sodium hypochlorite solution and minced, and IECs were released by 30-min incubation in 1 mM EGTA/1 mM EDTA on ice ([@bib20]). Samples were passed through a 70-µm filter, fixed in 70% ethanol, stained with propidium iodide and anti-CD45, and analyzed by FACS gating on the CD45^−^ IEC fraction with doublets discriminated (FACSCalibur and CellQuestPro; BD).

### ROS.

Colon pieces (proximal, mid, and distal) were incubated in Luminol Assay buffer (10 mM luminol in 1 mM CaCl~2~, 5 mM glucose in PBS) for 3 min and luminescence was measured ([@bib20]). Mean RLU/mean wet tissue weight was calculated.

### BrdU incorporation and quantification.

2.5 mg BrdU was injected 2 or 24 h before sacrificing mice ([@bib38]). BrdU^+^ cells were revealed by a BrdU staining kit (BD). BrdU^+^ cells per total cells along the crypt--villus axis were counted in five randomly selected crypt--villus axes per single sample.

### Statistical analysis.

Mean ± SEM is reported. Statistical significance was calculated using a two-tailed Student's *t* test, and significance was assumed for p-values \<0.05. Where more than two groups were compared, one-way ANOVA with Bonferroni's post-hoc testing was performed. Grubbs test was used to identify outliers. Data were analyzed using Excel (Microsoft) and Prism (GraphPad Software) software.

### Online supplemental material.

Table S1 shows primer sequences used in this study. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20122341/DC1>.
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